Alerts will be sent to your verified email
Verify EmailSHAMROIN
|
Shamrock Indl. Co
|
Parmax Pharma
|
Link Pharma Chem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 24.13 % | 5.2 % |
|
5yr average Equity Multiplier
|
1.02 | 29.23 | 1.99 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.05 | 1.33 |
|
5yr Avg Net Profit Margin
|
0.0 | -11.29 % | -0.06 % |
|
Price to Book
|
10.25 | 0.0 | 0.99 |
|
P/E
|
0.0 | 0.0 | 95.87 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -92.25 Days | 82.44 Days |
|
Inventory Days
|
0.0 | 69.37 Days | 64.96 Days |
|
Days Receivable
|
0.0 | 20.01 Days | 72.97 Days |
|
Days Payable
|
0.0 | 296.94 Days | 84.21 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | -0.77 | 2.35 |
|
5yr Avg ROCE
|
-8.65 % | -14.3 % | 5.35 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 2.43 % | 3.76 % |
|
5 yr average Debt to Equity
|
0.0 | 10.96 | 0.49 |
|
5yr CAGR Net Profit
|
-15.95 % | n/a | n/a |
|
5yr Average Return on Assets
|
-8.47 % | -9.05 % | 0.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.36 % | 30.8 % | 52.4 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 0.0 | 0.91 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Parmax Pharma
|
Link Pharma Chem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|